Pyc Therapeutics Ltd has released a press release.
ADOA Program - SRC Approve Progression to Multi-Dose Study
Earlier from Pyc Therapeutics
- Completion of Retail Entitlement Offer
- PKD Clinical Trial - Approval to Escalate Dosing
- Half Yearly Report and Accounts
- Retail Offer Booklet